LBLTF (Lattice Biologics) Cyclically Adjusted Book per Share: $0.00 (As of Jun. 2021)


What is Lattice Biologics Cyclically Adjusted Book per Share?

Lattice Biologics LBLTF -99.00% Cyclically Adjusted Book per Share is $0.00 as of Jun. 2021.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lattice Biologics's adjusted book value per share for the three months ended in Jun. 2021 was $0.001. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Jun. 2021.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-01), Lattice Biologics's current stock price is $0.0001. Lattice Biologics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2021 was $0.00. Lattice Biologics's Cyclically Adjusted PB Ratio of today is .


Lattice Biologics  (OTCPK:LBLTF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lattice Biologics Cyclically Adjusted Book per Share Related Terms


Lattice Biologics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Lattice Biologics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lattice Biologics Cyclically Adjusted Book per Share Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LBLTF vs ABT, MDT, SYK: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Lattice Biologics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lattice Biologics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Cyclically Adjusted PB Ratio falls into.



Lattice Biologics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lattice Biologics's adjusted Book Value per Share data for the three months ended in Jun. 2021 was:

Adj_Book= Book Value per Share /CPI of Jun. 2021 (Change)*Current CPI (Jun. 2021)
=0.001/271.6960*271.6960
=0.001

Current CPI (Jun. 2021) = 271.6960.

Lattice Biologics Quarterly Data

Book Value per Share CPI Adj_Book
201109 7.276 226.889 8.713
201112 0.131 225.672 0.158
201203 0.187 229.392 0.221
201206 0.077 229.478 0.091
201209 0.020 231.407 0.023
201212 -0.029 229.601 -0.034
201303 -0.081 232.773 -0.095
201306 -0.127 233.504 -0.148
201309 -0.153 234.149 -0.178
201312 -0.179 233.049 -0.209
201403 -0.182 236.293 -0.209
201406 -0.204 238.343 -0.233
201409 -0.212 238.031 -0.242
201412 -0.236 234.812 -0.273
201503 -0.234 236.119 -0.269
201506 -0.240 238.638 -0.273
201509 -0.275 237.945 -0.314
201512 -0.249 236.525 -0.286
201603 -0.100 238.132 -0.114
201606 -0.119 241.018 -0.134
201609 -0.093 241.428 -0.105
201612 -0.083 241.432 -0.093
201703 -0.088 243.801 -0.098
201706 -0.037 244.955 -0.041
201709 -0.046 246.819 -0.051
201712 -0.046 246.524 -0.051
201803 -0.049 249.554 -0.053
201806 -0.055 251.989 -0.059
201809 -0.057 252.439 -0.061
201812 -0.058 251.233 -0.063
201903 -0.057 254.202 -0.061
201906 -0.060 256.143 -0.064
201909 -0.068 256.759 -0.072
201912 -0.068 256.974 -0.072
202003 -0.077 258.115 -0.081
202006 -0.062 257.797 -0.065
202009 -0.050 260.280 -0.052
202012 -0.052 260.474 -0.054
202103 -0.012 264.877 -0.012
202106 0.001 271.696 0.001

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
Lattice Biologics (LBLTF) has a Cyclically Adjusted Book per Share of $0.00 as of Jun. 2021. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lattice Biologics and its competitors.
Is Lattice Biologics' Cyclically Adjusted Book per Share too high?
Lattice Biologics' current Cyclically Adjusted Book per Share is $0.00.
How does Lattice Biologics' Cyclically Adjusted Book per Share compare to ABT and MDT?
Lattice Biologics' Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lattice Biologics and its competitors. Lattice Biologics's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lattice Biologics stock overvalued right now?
Lattice Biologics (LBLTF) has a current Cyclically Adjusted Book per Share of $0.00. The current Cyclically Adjusted Book per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Lattice Biologics (LBLTF), the current Cyclically Adjusted Book per Share is $0.00 as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lattice Biologics Business Description

Address 512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The company's products include ADM dermis, DBM Putty, Bone scaffold, and others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.